Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fluvoxamine superior to TCAs in recurrent depression in France

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Fluvoxamine superior to TCAs in recurrent depression in France. Pharmacoecon. Outcomes News 184, 10 (1998). https://doi.org/10.1007/BF03277867

    Download citation

    Keywords

    • Markov Modelling
    • Tricyclic
    • Indirect Cost
    • Direct Cost
    • Maintenance Therapy